Victoria Treyger
General Partner and Managing Director @ Felicis
San Francisco, United States
Victoria Treyger is a seed investor at Felicis in San Francisco focused on Software and SaaS. Victoria Treyger is the General Partner and Managing Director at Felicis Ventures. Victoria is passionate about building great brands and scaling revenue through innovative sales and marketing. She joined Kabbage because she loved the opportunity to leverage technology and data to transform how financial services are delivered to customers.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 52%
Last updated:
For AI agents: llms.txt
Industries Victoria Treyger invests in
Stages Victoria Treyger invests in
Countries Victoria Treyger invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $3.3M–$14M
- Series A
- $11M–$63M
- Series B
- $30M–$63M
Investment Focus
Industry
- Software 8 (26%)
- SaaS 5 (16%)
- Health Care 5 (16%)
- FinTech 3 (10%)
- Women's 2 (6%)
Stage
- Seed 8 (26%)
- Series B 7 (23%)
- Series A 5 (16%)
- Series C 3 (10%)
- Series E 1 (3%)
Country
- United States 11 (35%)
- Australia 2 (6%)
- Canada 1 (3%)
- France 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Basata
|
Basata develops AI-powered tools that help healthcare practices manage administrative workflows such as referrals, scheduling, document processing, and patient communications. The company’s platform integrates with existing electronic health record systems and automates tasks related to faxes, phone calls, and patient intake. Its solutions aredesigned to reduce administrative workload for healthcare staff while improving the speed of patient scheduling and document handling. Basata also provides AI voice agents and document-processing systems that help healthcare organizations handle high volumes of operational tasks more efficiently. The company works with medical practices and healthcare networks to streamline back-office operations and improve coordination across administrative processes. | $21M / Series A / May 08, 2026 | |
Condor Software
|
Financial management software for biopharma | $24M / Series A / Mar 18, 2026 | |
ORO Labs
|
ORO Labs develops software that manages procurement workflows through a platform that coordinates business requests, supplier processes, and purchasing activities. The platform connects employees, internal systems, and data sources to guide procurement requests, approvals, and supplier interactions through structured workflows. It provides intakemanagement tools that capture requests and route them through purchasing and finance processes, while supplier onboarding and lifecycle management tools handle documentation, verification, and record updates.The platform includes automation features that support risk checks, compliance validation, and fraud detection during purchasing activities. It also offers configurable workflow tools and an AI agent builder that allows organizations to create automated processes for procurement tasks. ORO Labs integrates with enterprise systems such as ERP, contract management, and financial platforms to support processes from initial request through payment and supplier management. | $100M / Series C / Mar 12, 2026 | |
Midi Health
|
Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $100M / Series D / Feb 03, 2026 | |
Nilus
|
Nilus is a plug-and-play platform that automates reconciliation, reporting, and payment workflows to empower finance teams with financial transparency and complete control.By unifying data from your payment providers, banks, platform, and ERP, Nilus creates a single source of financial truth for all your payment activity.Nilus provides aseamless plug-and-play experience for financial operators. With our automated workflows, pre-built data connectors, and smart reconciliation algorithms, Nilus eliminates dependence on tech teams and spreadsheets to get the job done. | $10M / Jan 16, 2025 | |
Redactive
|
Redactive developer platform eliminates the need for developers to acquire, implement, and maintain specialized data engineering knowledge. This enables to build scalable and secure AI-enhanced applications for customers or productivity use cases for employees more efficiently. | $7.7M / Seed / Jul 03, 2024 | |
|
Midi Health
|
Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $63M / Series B / Apr 24, 2024 | |
|
ORO Labs
|
ORO Labs develops software that manages procurement workflows through a platform that coordinates business requests, supplier processes, and purchasing activities. The platform connects employees, internal systems, and data sources to guide procurement requests, approvals, and supplier interactions through structured workflows. It provides intakemanagement tools that capture requests and route them through purchasing and finance processes, while supplier onboarding and lifecycle management tools handle documentation, verification, and record updates.The platform includes automation features that support risk checks, compliance validation, and fraud detection during purchasing activities. It also offers configurable workflow tools and an AI agent builder that allows organizations to create automated processes for procurement tasks. ORO Labs integrates with enterprise systems such as ERP, contract management, and financial platforms to support processes from initial request through payment and supplier management. | $34M / Series B / Nov 01, 2023 | |
|
Midi Health
|
Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $25M / Series A / Sep 27, 2023 | |
|
Midi Health
|
Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $14M / Seed / Oct 27, 2022 | |
| See all 31 investments → | |||
Co-Investors
About Felicis
Felicis is a venture capital firm that focuses on backing founders who are building iconic companies capable of transcending boundaries. The firm invests directly in their growth, supporting innovative ideas across various sectors, including AI, health, and security.
Felicis Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Victoria Treyger
General Partner and Managing Director
|
|||
Astasia Myers
General Partner
|
|||
Aydin Senkut
Founder & Managing Partner
|
|||
Daniel Bartus
Partner, Head of Research
|
|||
Dasha Maggio
Partner & Head of Founder Success
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Victoria Treyger invest in?
Victoria Treyger invests primarily in Software, SaaS and Health Care startups, most often at Seed and Series B stage. Most of the 31 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Victoria Treyger's check size?
Victoria Treyger typically joins rounds of $3.3M–$14M at Seed, $11M–$63M at Series A and $30M–$63M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Victoria Treyger participates in.
How do I contact Victoria Treyger?
Public channels for Victoria Treyger include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Victoria Treyger last invest?
The most recent investment recorded for Victoria Treyger closed in May 2026. Shizune tracks 31 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
